Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251569 | SCV000308701 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000280623 | SCV000403341 | likely benign | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Athena Diagnostics Inc | RCV000084440 | SCV000843038 | benign | not provided | 2017-08-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311747 | SCV000846012 | benign | Inborn genetic diseases | 2016-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001516285 | SCV001724547 | benign | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ceroid lipofuscinosis 11 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000084440 | SCV001888915 | benign | not provided | 2018-08-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001516285 | SCV002796590 | benign | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ceroid lipofuscinosis 11 | 2021-08-23 | criteria provided, single submitter | clinical testing | |
VIB Department of Molecular Genetics, |
RCV000084440 | SCV000116576 | not provided | not provided | no assertion provided | not provided | ||
Mayo Clinic Laboratories, |
RCV000084440 | SCV000801382 | benign | not provided | 2015-12-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000251569 | SCV001741217 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000251569 | SCV001809588 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000251569 | SCV001930295 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000251569 | SCV001967226 | benign | not specified | no assertion criteria provided | clinical testing |